
CAS
18228-17-6
Formulation
A crystalline solid
Purity
≥98%
MW
377,715321
Shipment
-20
Long Term Storage
-20
Shelf Life
1460
Description
An inhibitor of the protein-protein interaction between CREB and KIX domains; disrupts binding between CREB and the KIX domain of CBP (Ki = 50 µM); inhibits binding of Myb to the KIX domains of p300 and CBP (IC50s = 30 and 43 µM, respectively); inhibits CREB-dependent transcription in HEK293T cells (Ki = 10 µM); decreases the expression of Myb target genes and induces differentiation in HL-60, U937, and NB4 myeloid leukemia cells at 5 µM; inhibits proliferation of NCI-H1734 lung adenocarcinoma cells (IC50 = 6.89 µM)
ESCLUSIVAMENTE PER USO DI RICERCA (RUO) e non per uso terapeutico o diagnostico su uomini o animali. Il prodotto NON è un Dispositivo Medico o un Diagnostico in Vitro.
PRODUCT FOR RESEARCH USE ONLY (RUO) and not for therapeutic or diagnostic use on humans or animals. The product is NOT a Medical Device or an In-Vitro Diagnostic (IVD).